Benjamin Kornitzer - 14 Apr 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role: Chief Med. & Quality Officer
Signature: /s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol: AGL
Transactions as of: 14 Apr 2023
Net transactions value: -$37,340
Form type: 4
Filing time: 18 Apr 2023, 16:46:55 UTC
Previous filing: 24 Mar 2023
Next filing: 18 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Award	$0	+4,393	+7.9%	$0.000000	59,819	14 Apr 2023	Direct	F1, F2
transaction	AGL	Common Stock	Tax liability	$37,340	-1,312	-2.2%	$28.46	58,507	14 Apr 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGL	Options (Rights to Buy)	Award	$0	+7,595		$0.000000	7,595	14 Apr 2023	Common Stock	7,595	$28.46	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.
F2	Includes restricted stock units.
F3	Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F4	Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.